You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.
Home › News & events

News & events

Innate Pharma updates on its next meetings with analysts and investors

April 17, 2009

Innate Pharma announces it will participate to the following analyst and investor conferences in the coming weeks:

  • BioCapital Europe, April 21, 2009, in Amsterdam, The Netherlands;
  • C,F&B Smallcap Event, April 27-28, 2009, in Paris, France;
  • BioEquity Europe, June 9-10, 2009, in Munich, Germany.

Financial results for 2008

February 27, 2009

Innate Pharma SA reports today its financial results for 2008: stable operational expenses and expanded R&D portfolio.

Milestone payment in IPH 24 project developed in collaboration with Novo Nordisk A/S

February 12, 2009

Innate Pharma SA  announces the achievement of a milestone payment in a new monoclonal antibody project developed in collaboration with Novo Nordisk A/S.

Operating revenue of 12.9 million Euros for the year 2008

February 6, 2009

Innate Pharma SA today announces an operating revenue of 12.9 million Euros for the year 2008. Turnover for the year amounted to 7.5 million Euros, including 1.6 million Euros in the fourth quarter ended December 31, 2008.

Vivalis and Innate Pharma sign a collaboration and commercial license agreement

January 21, 2009

Vivalis and Innate Pharma sign a collaboration and commercial license agreement to develop Innate's novel monoclonal antibody, to be manufactured with Vivalis' EB66® platform, for rare cutaneous cancers.

Financial and investor relations calendar for 2009

December 23, 2008

Innate Pharma SA announces its tentative financial and investor relations calendar for 2009.